Close

Emergent Biosolutions (EBS) Tops Q4 EPS by 6c, Offers Guidance

March 6, 2014 4:14 PM EST Send to a Friend
Emergent Biosolutions (NYSE: EBS) reported Q4 EPS of $0.42, $0.06 better than the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login